BioSpace News Archive

Genetown

Moderna to Build State-of-the-Art mRNA Facility in Africa to Manufacture up to 500 Million Doses Per Year

Moderna, Inc., a biotechnology company pioneering messenger RNA therapeutics and vaccines, announced it will build a state-of-the-art mRNA facility in Africa with the goal of producing up to 500 million doses of vaccines each year at the 50 µg dose level.

October 7, 2021
·
4 min read
Nerve Biologic Products Market in 2021 - Detailed Analysis Report with Forecast

The nerve biologic products market report is an-depth study of various trends, growth factors, and economic forecast.

October 7, 2021
·
4 min read
Healthcare EDI Market - Exclusive Report on the Latest Trends and Opportunities in the Market

Growing support from the worldwide government bodies for the implementation of healthcare information technology is projected to work as one of the key drivers for the expansion of the global healthcare EDI market throughout the forecast period 2020–2030.

October 7, 2021
·
4 min read
ENT Devices Market Survey | Demand for Cosmetic ENT Procedures is Observing Considerable Popularity

The ENT devices market is estimated to observe considerable growth during the forecast period of 2020-2030.

October 7, 2021
·
4 min read
Business

CytoDyn Names Chris Recknor, M.D. Senior Executive VP of Clinical Operations to Initiate Two New Clinical Trials for Stroke and Alzheimer’s

New hires in Bioanalytical Sciences, Biostatistics, Clinical Regulatory, and Clinical Project Management will join the team of Drs. Srinivasan, Recknor, Ray, and Kelly to lead all clinical trials with new CROs

October 7, 2021
·
11 min read
AiCuris Announces Opening of Second Round of AiCubator Corporate Innovation Accelerator Initiative to Propel Anti-infective Drug Development

Second round application period open through December 31, 2021; up to three projects will be awarded AiCubator Resident Status and, over a period of up to three years, will benefit from expert scientific advice

October 7, 2021
·
6 min read
Business

IONIQ Sciences Announces the Appointment of Aaron B. Dorny to its Board of Directors

IONIQ Sciences, Inc., is developing a rapid and non-invasive Multi-Cancer Screen for early detection that has the potential to expand the therapeutic window, dramatically improve survivability and reduce the cost of healthcare.

October 7, 2021
·
3 min read
Pharm Country

BD Unveils Nebraska-Based Manufacturing Capacity to Support U.S. Vaccination Agility and Preparedness

BD, a leading global medical technology company, announced it has strengthened the U.S. government’s access to safety injection devices through increased manufacturing capacity and domestic supply.

October 7, 2021
·
5 min read
Deals

ALX Oncology Strengthens Immuno-Oncology Pipeline with Acquisition of ScalmiBio

Acquisition adds novel and proprietary SHIELD platform for conditional activation of antibodies in tumor microenvironment and proprietary cytotoxic payloads for antibody drug conjugates

October 7, 2021
·
4 min read
Pharm Country

Outlook Therapeutics to Present at the 2021 American Society of Retina Specialists (ASRS) Annual Meeting

Outlook Therapeutics, Inc. today announced that Suber S. Huang, MD, MBA, FASRS, Co-Founder and CEO of the Retina Center of Ohio, will present data from Outlook Therapeutics’ NORSE THREE supplemental safety study for ONS-5010 / LYTENAVA™

October 7, 2021
·
2 min read